<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <sponsors>
      <item>
        <middleName />
        <fullName>Sen. Burr, Richard [R-NC]</fullName>
        <bioguideId>B001135</bioguideId>
        <party>R</party>
        <lastName>BURR</lastName>
        <byRequestType />
        <identifiers>
          <lisID>153</lisID>
          <gpoId>8286</gpoId>
          <bioguideId>B001135</bioguideId>
        </identifiers>
        <firstName>RICHARD</firstName>
        <state>NC</state>
      </item>
    </sponsors>
    <latestAction>
      <links />
      <actionDate>2016-03-14</actionDate>
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 388.</text>
    </latestAction>
    <laws />
    <updateDate>2018-06-02T07:09:58Z</updateDate>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <introducedDate>2015-09-17</introducedDate>
    <amendments />
    <actions>
      <actionByCounts>
        <senate>6</senate>
      </actionByCounts>
      <item>
        <actionDate>2016-03-14</actionDate>
        <committee />
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 388.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2016-03-14</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-03-14</actionDate>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.</text>
        <type>Committee</type>
        <links />
        <actionCode>14000</actionCode>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
      </item>
      <item>
        <actionDate>2016-03-09</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-09-17</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2015-09-17</actionDate>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <links />
        <actionCode>10000</actionCode>
        <committee />
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <placedOnCalendarGeneralOrders>1</placedOnCalendarGeneralOrders>
        <reportedToSenate>2</reportedToSenate>
        <orderedReported>1</orderedReported>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
    </actions>
    <originChamber>Senate</originChamber>
    <createDate>2015-09-18T09:22:53Z</createDate>
    <billType>S</billType>
    <relatedBills>
      <item>
        <type>HR</type>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <latestAction>
          <text>Became Public Law No: 114-255.</text>
          <actionDate>2016-12-13</actionDate>
        </latestAction>
        <number>34</number>
        <latestTitle>21st Century Cures Act</latestTitle>
      </item>
    </relatedBills>
    <cboCostEstimates>
      <item>
        <pubDate>2016-08-09T20:57:00Z</pubDate>
        <url>https://www.cbo.gov/publication/51886</url>
        <title>S. 2055, Medical Countermeasure Innovation Act of 2016</title>
      </item>
    </cboCostEstimates>
    <recordedVotes />
    <calendarNumbers>
      <item>
        <number>0388</number>
        <calendar>Senate Calendar of Business</calendar>
      </item>
    </calendarNumbers>
    <version>1.0.0</version>
    <cosponsors>
      <item>
        <state>PA</state>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-09-17</sponsorshipDate>
        <firstName>Bob</firstName>
        <middleName />
        <bioguideId>C001070</bioguideId>
        <identifiers>
          <bioguideId>C001070</bioguideId>
          <gpoId>8282</gpoId>
          <lisID>1828</lisID>
        </identifiers>
        <fullName>Sen. Casey, Robert P., Jr. [D-PA]</fullName>
        <lastName>Casey</lastName>
        <party>D</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <state>GA</state>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-10-26</sponsorshipDate>
        <firstName>Johnny</firstName>
        <middleName />
        <bioguideId>I000055</bioguideId>
        <identifiers>
          <bioguideId>I000055</bioguideId>
          <gpoId>8323</gpoId>
          <lisID>1608</lisID>
        </identifiers>
        <fullName>Sen. Isakson, Johnny [R-GA]</fullName>
        <lastName>Isakson</lastName>
        <party>R</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <state>KS</state>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2015-11-19</sponsorshipDate>
        <firstName>PAT</firstName>
        <middleName />
        <bioguideId>R000307</bioguideId>
        <identifiers>
          <bioguideId>R000307</bioguideId>
          <gpoId>8275</gpoId>
          <lisID>968</lisID>
        </identifiers>
        <fullName>Sen. Roberts, Pat [R-KS]</fullName>
        <lastName>ROBERTS</lastName>
        <party>R</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <state>TN</state>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2016-03-15</sponsorshipDate>
        <firstName>Lamar</firstName>
        <middleName />
        <bioguideId>A000360</bioguideId>
        <identifiers>
          <gpoId>8304</gpoId>
          <bioguideId>A000360</bioguideId>
          <lisID>1695</lisID>
        </identifiers>
        <fullName>Sen. Alexander, Lamar [R-TN]</fullName>
        <lastName>Alexander</lastName>
        <party>R</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <titles>
      <item>
        <chamberCode>S</chamberCode>
        <parentTitleType>Short Titles Senate</parentTitleType>
        <title>Medical Countermeasure Innovation Act of 2016</title>
        <chamberName>Senate</chamberName>
        <titleType>Short Titles as Reported to Senate</titleType>
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <title>Medical Countermeasure Innovation Act of 2015</title>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <title>A bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to national health security.</title>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <title>Medical Countermeasure Innovation Act of 2016</title>
        <chamberName />
        <titleType>Display Title</titleType>
      </item>
    </titles>
    <committeeReports />
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Animal protection and human-animal relationships</name>
          </item>
          <item>
            <name>Chemical and biological weapons</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Emergency medical services and trauma care</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Immunology and vaccination</name>
          </item>
          <item>
            <name>Infectious and parasitic diseases</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Nuclear weapons</name>
          </item>
          <item>
            <name>Research administration and funding</name>
          </item>
          <item>
            <name>Terrorism</name>
          </item>
          <item>
            <name>User charges and fees</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <systemCode>sshr00</systemCode>
          <activities>
            <item>
              <date>2016-03-14T20:24:37Z</date>
              <name>Reported by</name>
            </item>
            <item>
              <date>2016-03-09T15:00:00Z</date>
              <name>Markup by</name>
            </item>
            <item>
              <date>2015-09-17T20:21:17Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <subcommittees />
          <chamber>Senate</chamber>
        </item>
      </billCommittees>
    </committees>
    <billNumber>2055</billNumber>
    <summaries>
      <billSummaries>
        <item>
          <actionDesc>Introduced in Senate</actionDesc>
          <text><![CDATA[<p><b>Medical Countermeasure Innovation Act of 2015</b></p> <p>This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to ensure the issuance of timely and accurate guidelines regarding the use of medical products for countering public health emergencies or material threats.</p> <p>The Biomedical Advanced Research and Development Authority's contracting authority for procurement of medical countermeasures under Project BioShield is codified. Such procurement no longer requires Presidential approval or an agreement between HHS and the Department of Homeland Security.</p> <p>The Office of the Assistant Secretary for Preparedness and Response must publish its budget plan for medical countermeasures.</p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to explain delays in finalizing guidance regarding development of animal models to support approval of medical countermeasures.</p> <p>Upon approval, the FDA must award a priority review voucher to the sponsor of a drug or biological product that: (1) is a significant improvement in the prevention, diagnosis, or treatment of a serious condition; and (2) can be used as a medical countermeasure to a material threat. The transferable voucher entitles the holder to have a new medication application acted upon by the FDA within six months.</p> <p>The sponsor of a medication that is subject to a voucher must pay a user fee based on the FDA's cost for the priority review process.</p> The FDA must publish a notice each time it issues a voucher or a voucher is used.]]></text>
          <lastSummaryUpdateDate>2016-05-19T19:50:55Z</lastSummaryUpdateDate>
          <actionDate>2015-09-17</actionDate>
          <updateDate>2015-09-17T04:00:00Z</updateDate>
          <versionCode>00</versionCode>
          <name>Introduced in Senate</name>
        </item>
        <item>
          <actionDesc>Reported to Senate with amendment(s)</actionDesc>
          <text><![CDATA[<p><b>Medical Countermeasure Innovation Act of 2016</b></p> <p>(Sec. 2) This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to ensure the issuance of timely and accurate guidelines regarding the use of medical products for countering public health emergencies or material threats. HHS must report on funding for procurement of medical countermeasures when available funds are below a specified amount.</p> <p>(Sec. 3) The Biomedical Advanced Research and Development Authority's (BARDA's) contracting authority for procurement of medical countermeasures under Project BioShield is codified.</p> <p>(Sec. 4) The Office of the Assistant Secretary for Preparedness and Response must annually publish its budget plan for medical countermeasures.</p> <p>(Sec. 5) BARDA may enter an agreement with an independent, nongovernmental nonprofit to foster and accelerate the development and innovation of medical countermeasures and related technologies. BARDA must direct and oversee the nonprofit's work and ensure transparency and accountability.</p> <p>(Sec. 6) BARDA's procurement of medical countermeasures no longer requires Presidential approval or an agreement between HHS and the Department of Homeland Security.</p> <p>(Sec. 7) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to award, upon approval, a priority review voucher to the sponsor of a drug or biological product that: (1) is a significant improvement in the prevention, diagnosis, or treatment of a serious condition; and (2) can be used as a medical countermeasure to a material threat. The transferable voucher entitles the holder to have an application for a new medication acted upon by the FDA within six months.</p> <p>The sponsor of a medication that is subject to a voucher must pay a user fee based on the FDA's cost for the priority review process.</p> <p>The FDA must publish a notice each time it issues a voucher or a voucher is used. </p> <p>(Sec. 8) The Government Accountability Office must report on the effectiveness of this priority review voucher program in providing incentives for the development of material threat medical countermeasures.</p>]]></text>
          <lastSummaryUpdateDate>2016-07-08T15:35:01Z</lastSummaryUpdateDate>
          <actionDate>2016-03-14</actionDate>
          <updateDate>2016-03-14T13:19:05Z</updateDate>
          <versionCode>01</versionCode>
          <name>Reported to Senate with amendment(s)</name>
        </item>
      </billSummaries>
    </summaries>
    <congress>114</congress>
    <notes />
    <title>Medical Countermeasure Innovation Act of 2016</title>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

